AxoGen, Inc. (AXGN)
USD 16.14
(-5.28%)
USD 16.14
(-5.28%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 159.01 Million USD | 14.74% |
| 2022 | 138.58 Million USD | 8.81% |
| 2021 | 127.35 Million USD | 13.41% |
| 2020 | 112.3 Million USD | 5.24% |
| 2019 | 106.71 Million USD | 27.13% |
| 2018 | 83.93 Million USD | 38.91% |
| 2017 | 60.42 Million USD | 47.0% |
| 2016 | 41.1 Million USD | 50.41% |
| 2015 | 27.33 Million USD | 62.52% |
| 2014 | 16.81 Million USD | 53.62% |
| 2013 | 10.94 Million USD | 42.33% |
| 2012 | 7.69 Million USD | 58.61% |
| 2011 | 4.84 Million USD | 5213.15% |
| 2010 | 91.27 Thousand USD | -99.63% |
| 2009 | 24.91 Million USD | 34160.81% |
| 2008 | 72.71 Thousand USD | -27.6% |
| 2007 | 100.43 Thousand USD | -20.71% |
| 2006 | 126.66 Thousand USD | -71.43% |
| 2005 | 443.35 Thousand USD | -58.37% |
| 2004 | 1.06 Million USD | -85.28% |
| 2003 | 7.23 Million USD | 5.62% |
| 2002 | 6.85 Million USD | -56.98% |
| 2001 | 15.92 Million USD | 9.13% |
| 2000 | 14.59 Million USD | 18.67% |
| 1999 | 12.3 Million USD | -4.65% |
| 1998 | 12.9 Million USD | 4.88% |
| 1997 | 12.3 Million USD | -6.11% |
| 1996 | 13.1 Million USD | -7.09% |
| 1995 | 14.1 Million USD | 31.78% |
| 1994 | 10.7 Million USD | 16.3% |
| 1993 | 9.2 Million USD | 13.58% |
| 1992 | 8.1 Million USD | 1.25% |
| 1991 | 8 Million USD | 17.65% |
| 1990 | 6.8 Million USD | 6.25% |
| 1989 | 6.4 Million USD | 10.34% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 47.91 Million USD | 15.79% |
| 2024 Q1 | 41.37 Million USD | -3.6% |
| 2023 Q1 | 36.66 Million USD | 1.38% |
| 2023 Q2 | 38.15 Million USD | 4.07% |
| 2023 Q3 | 41.27 Million USD | 8.17% |
| 2023 FY | 159.01 Million USD | 14.74% |
| 2023 Q4 | 42.92 Million USD | 4.0% |
| 2022 Q3 | 36.95 Million USD | 7.27% |
| 2022 Q4 | 36.16 Million USD | -2.15% |
| 2022 FY | 138.58 Million USD | 8.81% |
| 2022 Q1 | 31 Million USD | -1.68% |
| 2022 Q2 | 34.45 Million USD | 11.12% |
| 2021 Q4 | 31.53 Million USD | 1.07% |
| 2021 Q2 | 33.58 Million USD | 8.19% |
| 2021 Q1 | 31.03 Million USD | -4.49% |
| 2021 Q3 | 31.2 Million USD | -7.08% |
| 2021 FY | 127.35 Million USD | 13.41% |
| 2020 Q1 | 24.26 Million USD | -13.85% |
| 2020 FY | 112.3 Million USD | 5.24% |
| 2020 Q2 | 22.11 Million USD | -8.84% |
| 2020 Q3 | 33.42 Million USD | 51.15% |
| 2020 Q4 | 32.49 Million USD | -2.79% |
| 2019 Q3 | 28.56 Million USD | 6.98% |
| 2019 Q1 | 23.28 Million USD | -0.63% |
| 2019 Q2 | 26.7 Million USD | 14.67% |
| 2019 FY | 106.71 Million USD | 27.13% |
| 2019 Q4 | 28.16 Million USD | -1.41% |
| 2018 Q2 | 20.58 Million USD | 19.26% |
| 2018 Q1 | 17.25 Million USD | 1.7% |
| 2018 Q3 | 22.66 Million USD | 10.08% |
| 2018 FY | 83.93 Million USD | 38.91% |
| 2018 Q4 | 23.43 Million USD | 3.41% |
| 2017 Q4 | 16.97 Million USD | 5.76% |
| 2017 FY | 60.42 Million USD | 47.0% |
| 2017 Q2 | 15.16 Million USD | 23.91% |
| 2017 Q3 | 16.04 Million USD | 5.79% |
| 2017 Q1 | 12.24 Million USD | 7.3% |
| 2016 FY | 41.1 Million USD | 50.41% |
| 2016 Q4 | 11.4 Million USD | 1.82% |
| 2016 Q2 | 10.38 Million USD | 27.99% |
| 2016 Q3 | 11.2 Million USD | 7.93% |
| 2016 Q1 | 8.11 Million USD | 3.88% |
| 2015 Q3 | 8.15 Million USD | 27.06% |
| 2015 Q1 | 4.95 Million USD | 3.29% |
| 2015 FY | 27.33 Million USD | 62.52% |
| 2015 Q4 | 7.8 Million USD | -4.23% |
| 2015 Q2 | 6.41 Million USD | 29.61% |
| 2014 Q2 | 4.21 Million USD | 34.28% |
| 2014 FY | 16.81 Million USD | 53.62% |
| 2014 Q1 | 3.13 Million USD | 5.15% |
| 2014 Q3 | 4.67 Million USD | 10.85% |
| 2014 Q4 | 4.79 Million USD | 2.62% |
| 2013 FY | 10.94 Million USD | 42.33% |
| 2013 Q4 | 2.98 Million USD | 0.92% |
| 2013 Q3 | 2.95 Million USD | 3.33% |
| 2013 Q2 | 2.86 Million USD | 33.57% |
| 2013 Q1 | 2.14 Million USD | 4.79% |
| 2012 Q4 | 2.04 Million USD | 3.23% |
| 2012 Q3 | 1.98 Million USD | -1.57% |
| 2012 Q2 | 2.01 Million USD | 21.72% |
| 2012 Q1 | 1.65 Million USD | 21.43% |
| 2012 FY | 7.69 Million USD | 58.61% |
| 2011 Q4 | 1.36 Million USD | 19.36% |
| 2011 FY | 4.84 Million USD | 5213.15% |
| 2011 Q1 | 3.62 Million USD | 8506.99% |
| 2011 Q2 | 2.24 Million USD | -38.09% |
| 2011 Q3 | 1.14 Million USD | -49.17% |
| 2010 FY | 91.27 Thousand USD | -99.63% |
| 2010 Q4 | 42.11 Thousand USD | 59.7% |
| 2010 Q1 | 19.52 Thousand USD | -99.92% |
| 2010 Q2 | 3254.00 USD | -83.34% |
| 2010 Q3 | 26.37 Thousand USD | 710.48% |
| 2009 FY | 24.91 Million USD | 34160.81% |
| 2009 Q1 | 42.1 Thousand USD | 29.22% |
| 2009 Q2 | 610.31 Thousand USD | 1349.43% |
| 2009 Q3 | 24.21 Thousand USD | -96.03% |
| 2009 Q4 | 24.23 Million USD | 99981.53% |
| 2008 Q4 | 32.58 Thousand USD | 132.39% |
| 2008 Q2 | 5075.00 USD | -75.87% |
| 2008 Q1 | 21.02 Thousand USD | 0.0% |
| 2008 FY | 72.71 Thousand USD | -27.6% |
| 2008 Q3 | 14.02 Thousand USD | 176.3% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | 100.43 Thousand USD | -20.71% |
| 2006 FY | 126.66 Thousand USD | -71.43% |
| 2006 Q4 | - USD | -100.0% |
| 2006 Q3 | 34.38 Thousand USD | 0.0% |
| 2006 Q2 | - USD | -100.0% |
| 2006 Q1 | 92.27 Thousand USD | -63.69% |
| 2005 Q3 | 68.71 Thousand USD | 75.38% |
| 2005 FY | 443.35 Thousand USD | -58.37% |
| 2005 Q4 | 254.15 Thousand USD | 269.86% |
| 2005 Q2 | 39.18 Thousand USD | -51.8% |
| 2005 Q1 | 81.29 Thousand USD | 0.0% |
| 2004 Q1 | 2.47 Million USD | 24.66% |
| 2004 Q3 | - USD | -100.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q2 | 1.52 Million USD | -38.69% |
| 2004 FY | 1.06 Million USD | -85.28% |
| 2003 Q3 | 1.97 Million USD | 21.77% |
| 2003 Q4 | 1.98 Million USD | 0.55% |
| 2003 Q1 | 1.64 Million USD | -5.45% |
| 2003 FY | 7.23 Million USD | 5.62% |
| 2003 Q2 | 1.62 Million USD | -1.29% |
| 2002 Q2 | 1.58 Million USD | 4.52% |
| 2002 FY | 6.85 Million USD | -56.98% |
| 2002 Q3 | 2.01 Million USD | 27.22% |
| 2002 Q4 | 1.74 Million USD | -13.57% |
| 2002 Q1 | 1.51 Million USD | 0.0% |
| 2001 Q3 | 2.72 Million USD | -22.4% |
| 2001 FY | 15.92 Million USD | 9.13% |
| 2001 Q1 | 4.17 Million USD | 2.84% |
| 2001 Q2 | 3.51 Million USD | -15.82% |
| 2000 FY | 14.59 Million USD | 18.67% |
| 2000 Q2 | 4.35 Million USD | 10.63% |
| 2000 Q1 | 3.93 Million USD | 19.24% |
| 2000 Q4 | 4.05 Million USD | -3.16% |
| 2000 Q3 | 4.18 Million USD | -3.77% |
| 1999 Q1 | 3.2 Million USD | 3.23% |
| 1999 Q2 | 3.1 Million USD | -3.13% |
| 1999 Q3 | 3 Million USD | -3.23% |
| 1999 Q4 | 3.3 Million USD | 10.0% |
| 1999 FY | 12.3 Million USD | -4.65% |
| 1998 FY | 12.9 Million USD | 4.88% |
| 1998 Q3 | 2.9 Million USD | 7.41% |
| 1998 Q4 | 3.1 Million USD | 6.9% |
| 1998 Q2 | 2.7 Million USD | -18.18% |
| 1998 Q1 | 3.3 Million USD | 0.0% |
| 1997 Q1 | 3 Million USD | 0.0% |
| 1997 FY | 12.3 Million USD | -6.11% |
| 1997 Q4 | 3.3 Million USD | -8.33% |
| 1997 Q3 | 3.6 Million USD | 9.09% |
| 1997 Q2 | 3.3 Million USD | 10.0% |
| 1996 FY | 13.1 Million USD | -7.09% |
| 1996 Q3 | 3 Million USD | 15.38% |
| 1996 Q4 | 3 Million USD | 0.0% |
| 1996 Q2 | 2.6 Million USD | -31.58% |
| 1996 Q1 | 3.8 Million USD | 15.15% |
| 1995 Q3 | 3.5 Million USD | 6.06% |
| 1995 Q1 | 4.2 Million USD | 13.51% |
| 1995 FY | 14.1 Million USD | 31.78% |
| 1995 Q4 | 3.3 Million USD | -5.71% |
| 1995 Q2 | 3.3 Million USD | -21.43% |
| 1994 Q1 | 2.3 Million USD | -8.0% |
| 1994 Q3 | 2.9 Million USD | 3.57% |
| 1994 FY | 10.7 Million USD | 16.3% |
| 1994 Q4 | 3.7 Million USD | 27.59% |
| 1994 Q2 | 2.8 Million USD | 21.74% |
| 1993 FY | 9.2 Million USD | 13.58% |
| 1993 Q3 | 3.1 Million USD | 6.9% |
| 1993 Q4 | 2.5 Million USD | -19.35% |
| 1993 Q1 | 2.3 Million USD | 21.05% |
| 1993 Q2 | 2.9 Million USD | 26.09% |
| 1992 Q2 | 2.1 Million USD | 5.0% |
| 1992 Q4 | 1.9 Million USD | -9.52% |
| 1992 Q3 | 2.1 Million USD | 0.0% |
| 1992 Q1 | 2 Million USD | 5.26% |
| 1992 FY | 8.1 Million USD | 1.25% |
| 1991 Q1 | 2.1 Million USD | 5.0% |
| 1991 Q4 | 1.9 Million USD | -9.52% |
| 1991 FY | 8 Million USD | 17.65% |
| 1991 Q3 | 2.1 Million USD | -4.55% |
| 1991 Q2 | 2.2 Million USD | 4.76% |
| 1990 FY | 6.8 Million USD | 6.25% |
| 1990 Q2 | -13.1 Million USD | -225.96% |
| 1990 Q1 | 10.4 Million USD | 38.67% |
| 1990 Q4 | 2 Million USD | 17.65% |
| 1990 Q3 | 1.7 Million USD | 112.98% |
| 1989 Q1 | 1.6 Million USD | -5.88% |
| 1989 FY | 6.4 Million USD | 10.34% |
| 1989 Q4 | 7.5 Million USD | 294.74% |
| 1989 Q3 | 1.9 Million USD | 18.75% |
| 1989 Q2 | 1.6 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -1218.617% |
| BrainsWay Ltd. | 31.78 Million USD | -400.274% |
| Cerus Corporation | 156.36 Million USD | -1.692% |
| Envoy Medical, Inc. | 316 Thousand USD | -50220.253% |
| electroCore, Inc. | 16.03 Million USD | -891.965% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -24591.304% |
| IceCure Medical Ltd | 3.22 Million USD | -4824.497% |
| Inogen, Inc. | 315.66 Million USD | 49.626% |
| OrthoPediatrics Corp. | 148.73 Million USD | -6.912% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -6449.094% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -43465.051% |
| MaxCyte, Inc. | 41.28 Million USD | -285.129% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -8044.267% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -143480.02% |
| Orthofix Medical Inc. | 746.64 Million USD | 78.703% |
| PAVmed Inc | 2.45 Million USD | -6384.992% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -606.124% |
| RxSight, Inc. | 89.07 Million USD | -78.511% |
| Sight Sciences, Inc. | 81.05 Million USD | -96.175% |
| SI-BONE, Inc. | 138.88 Million USD | -14.491% |
| TELA Bio, Inc. | 58.45 Million USD | -172.034% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 15.02% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -1052.177% |
| Acutus Medical, Inc. | 7.16 Million USD | -2119.598% |
| Talis Biomedical Corporation | 412 Thousand USD | -38495.146% |
| Spectral AI, Inc. | 18.05 Million USD | -780.66% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -1505.371% |
| CVRx, Inc. | 39.29 Million USD | -304.662% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -16314.887% |
| Bioventus Inc. | 512.34 Million USD | 68.964% |
| Venus Concept Inc. | 76.35 Million USD | -108.256% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -759.014% |
| LivaNova PLC | 1.15 Billion USD | 86.215% |
| 908 Devices Inc. | 50.22 Million USD | -216.574% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 67.028% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -206291.153% |
| NeuroPace, Inc. | 65.42 Million USD | -143.06% |
| LENSAR, Inc. | 42.16 Million USD | -277.127% |
| Apyx Medical Corporation | 52.34 Million USD | -203.754% |
| Cutera, Inc. | 212.36 Million USD | 25.125% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -376.683% |
| BioSig Technologies, Inc. | 18 Thousand USD | -883300.0% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 4.59% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -563.795% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 89.685% |
| Axonics, Inc. | 366.37 Million USD | 56.599% |
| Outset Medical, Inc. | 130.37 Million USD | -21.964% |
| IRIDEX Corporation | 51.86 Million USD | -206.565% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | -16.757% |
| IRadimed Corporation | 65.56 Million USD | -142.536% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -13421.429% |
| INVO Bioscience, Inc. | 3.02 Million USD | -5164.296% |
| Telesis Bio, Inc. | 27.5 Million USD | -478.036% |
| Viemed Healthcare, Inc. | 183 Million USD | 13.112% |
| Varex Imaging Corporation | 811 Million USD | 80.393% |
| Quipt Home Medical Corp. | 221.74 Million USD | 28.29% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -131.543% |
| Dynatronics Corporation | 32.53 Million USD | -388.757% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -1732.358% |
| Semler Scientific, Inc. | 68.18 Million USD | -133.21% |
| InMode Ltd. | 492.04 Million USD | 67.684% |
| Bruker Corporation | 2.96 Billion USD | 94.636% |
| Cytosorbents Corporation | 36.34 Million USD | -337.455% |
| DexCom, Inc. | 3.62 Billion USD | 95.61% |
| Align Technology, Inc. | 3.86 Billion USD | 95.883% |
| Viveve Medical, Inc. | 6.42 Million USD | -2374.51% |
| ZimVie Inc. | 457.43 Million USD | 65.238% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 17.617% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -143480.02% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 78.734% |
| Profound Medical Corp. | 7.33 Million USD | -2069.029% |
| Insulet Corporation | 1.69 Billion USD | 90.63% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | -26.122% |
| iCAD, Inc. | 17.31 Million USD | -818.189% |
| Nuwellis, Inc. | 8.86 Million USD | -1693.908% |
| Biotricity, Inc. | 12.06 Million USD | -1218.142% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 67.725% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -2462.643% |
| PAVmed Inc. | 2.45 Million USD | -6384.992% |
| BIOLASE, Inc. | 49.16 Million USD | -223.432% |
| Beyond Air, Inc. | 1.15 Million USD | -13619.758% |
| FONAR Corporation | 102.88 Million USD | -54.555% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 42.056% |
| Inari Medical, Inc. | 493.63 Million USD | 67.787% |
| UFP Technologies, Inc. | 400.07 Million USD | 60.254% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -854803.226% |
| Tenon Medical, Inc. | 2.92 Million USD | -5330.738% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -2234.279% |
| AdaptHealth Corp. | 3.2 Billion USD | 95.031% |
| Sintx Technologies, Inc. | 2.62 Million USD | -5952.988% |
| NanoVibronix, Inc. | 2.28 Million USD | -6865.046% |
| Quanterix Corporation | 122.36 Million USD | -29.946% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -551.555% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 20.701% |
| TransMedics Group, Inc. | 241.62 Million USD | 34.19% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -1047.77% |
| NeuroMetrix, Inc. | 5.9 Million USD | -2594.468% |
| Hyperfine, Inc. | 11.03 Million USD | -1341.371% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 3.717% |
| Biomerica, Inc. | 5.41 Million USD | -2836.51% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -214.495% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 10.231% |